We investigated the effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and recombinant human granulocyte-CSF (rhG-CSF) on the generation of natural killer (NK) cells in vitro. NK cells were cultured from selected human bone marrow cells obtained after the elimination of mature T and NK cells. rhGM-CSF significantly suppressed the generation of CD56+ cells and NK activity (P < .01) in a dose-dependent manner. The gener-LTHOUGH natural killer (NK) cells are considered to A be derived from the bone marrow (BM),1-8 little is known about the mechanism of their differentiation and proliferation. It has been shown that interleukin-2 (IL-2) is the major cytokine necessary for the differentiation of human NK progenitors in vitr0.9-l~ However, the development of these NK progenitor cells may also be regulated by the many other cytokines that have complex effects on the generation of BM-derived c e l l~. ~J~ We recently reported that peripheral blood (PB) NK cells and the frequency of BM NK progenitors were decreased in patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS) who received therapy with recombinant human granulocyte-macrophage colonystimulating factor (rhGM-CSF),15 suggesting that GM-CSF suppressed the generation of NK cells in vivo.
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We have previously reported that NK cells can be cultured from human BM cells in recombinant human IL-2 (rIL-2)-containing medium after the extensive depletion of nylon wool (NW)-adherent cells and mature T and NK cells.g This culture system is useful for studying of the effects of cytokines on the generation of NK cells from human NK progenitors. To confirm the inhibitory effect of GM-CSF on the generation of NK cells in vivo and to clarify its mechanism, we investigated whether rhGM-CSF suppressed the in vitro generation of NK cells using this culture system.
MATERIALS AND METHODS
Preparation of PB and BM cells. PB was collected into a heparinized syringe by venipuncture from three healthy volunteers and mononuclear cells (MNC) were separated from the blood by Ficoll-Hypaque gradient centrifugation. BM was aspirated from the sternum of five healthy volunteers and 4 mL was diluted quickly in 15 mL of Hanks' Balanced Salt Solution containing heparin. BM MNC were then separated by centrifugation in the same manner as for PB MNC.
BM MNC were suspended in RPMI 1640 medium supplemented with 5% fetal calf serum (FCS; GIBCO, Grand Island, NY). The cell suspension was passed through an NW column and nonadherent cells were collected. Subsequently, mature T and NK cells were eliminated as described previo~sly.~ In brief, 1.5 x lo7 NW nonadherent BM cells suspended in 3 mL of medium were mixed with 1.5 x lo9 2-aminoethylisothiouronium hydrobromide-treated sheep red blood cells (AET-SRBC), incubated for 15 minutes at 3 7 T , and then incubated for a further 30 minutes at 4°C. The cells were then resuspended gently and AET-SRBC rosette-forming cells were eliminated by FicollHypaque gradient centrifugation. Non-rosette-forming cells were
Pretreatment of BM cells.
ation of large granular lymphocytes (LGL) was also suppressed in the presence of rhGM-CSF (P < .01). In contrast, rhG-CSF had no effect on LGL (P > U/mL of rIL-2 (Shionogi Pharmaceutical, Osaka, Japan), various doses (0, lo2, lo3, and lo4 pg/mL) of rhGM-CSF (Schering-Plough, Osaka, Japan) or recombinant human granulocyte-CSF (rhG-CSF; Chugai Pharmaceutical, Tokyo, Japan), and 1 x l@/mL unselected autologous irradiated (50 Gy) BM cells were added to each well. The irradiated BM MNC were used on the basis of our preliminary observation that 3H uptake and generation of NK activity of the selected BM cells increased when these irradiated feeder cells were added. The selected BM cells were cultured for 21 days. Half of the medium was replaced with medium containing the same doses of rIL-2 and either rhGM-CSF or rhG-CSF on days 7 and 14.
To investigate the effects of rhGM-CSF and rhG-CSF on mature NK cells, PB MNC were cultured in the presence of rhGM-CSF or rhG-CSF. Aliquots of 100 pL of the complete medium containing 5 x 104 PB MNC were placed in Immunofluorescent analysk of selected BM celk and NK cell counts. Expression of surface antigens of selected BM cells before and after culture was analyzed with a FACScan (Becton Dickinson). Two-color immunofluorescent staining was performed using the direct staining method. The cells were incubated simultaneously with 2 p,g/mL fluorescein isothiocyanate (F1TC)-conjugated CD3 (Leu4; Becton Dickinson) and 2 pg/mL phycoerythrinconjugated CD56 ( " 1 ; Coulter Clone, Hialeah, FL) for 30 minutes at 4°C followed by two washings before analysis. Background fluorescence was determined using cells incubated with fluorescein-conjugated isotype-matched mouse monoclonal IgG (Becton Dickinson).
The NK cell count was determined as the total viable cell count per well multiplied by the percentage of CD56+ cells x 1/1OO. The counting of NK cells was performed before and 7,14, and 21 days after starting the culture of selected BM cells, as well as before and 1,3,5,7,10, and 14 days after starting the culture of PB MNC.
After culture, the selected BM cells were suspended in RPMI 1640 supplemented with 5% FCS. K562 target cells were labeled with 50 kCi of T r for 2 hours at 37°C and then washed extensively before use. Target cells (5 x 103) suspended in 10 pL of medium and effector cells in 0.1 mL of medium were plated in microtiter wells at several effectorharget ratios (201, lO:l, 5:1, 231). After 4 hours of incubation at 3TC, the supematant was harvested using the Titertek system (Flow Laboratories) and its radioactivity was measured with a gamma counter (Gamma 5500; Beckmann Instruments Inc, Irvine, CA). Cytotoxicity was determined from the amount of 51Cr released by the lysed target cells. Triplicate determinations were made and T r release was NK (ZC562) activity. L of medium) were centrifuged onto microscope slides for 3 minutes at 800 rpm, using an automatic cytospinner (Autosmear CF12D; Sakura Fine Technical, Tokyo, Japan). Slides were rapidly air-dried and then stained using Wright's stain (Muto Pure Chemicals, Tokyo, Japan). Cytochemical staining with a-naphthyl butyrate esterase was also performed to identify macrophages. 16 The cells were observed using a light microscope and were divided into granulocytes, macrophages, large granular lymphocytes (LGL; lymphoid cells with abundant clear cytoplasm and multiple azurophilic granules), and other cells, including erythroid cells and lymphocytes apart from LGL. Morphologic studies were performed before and 7, 14, and 21 days after starting the culture of selected BM cells obtained from three healthy volunteers.
Statistical analysis was performed using the Student's paired t-test and P < .OS was taken as significant.
Statistical analysis.

RESULTS
Immunofluorescent analysis of selected BM celkr. To confirm the elimination of mature T and NK cells from BM MNC and the specificity of the generation of NK cells, we analyzed the surface antigens of CD3 and CD56 on the selected BM cells before culture and after culture for 21 days. No residual CD3+ and CD56+ cells were observed in the selected BM cells before culture (Fig lA) , indicating CD 3 -FlTC For
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that the negative immunoselection of BM MNC eliminate completely mature T and NK cells. The CD56+ cells generated from selected BM cells 21 days after culture did not coexpress CD3 antigen (Fig lB) , indicating that the CD56+ cells generated after culture were not T cells but NK cells. Fig 2, the total cell count, CD56+ cell count, and NK activity in each well were decreased in a dose-dependent manner in the presence of rhGM-CSF. The total cell counts after culture with rhGM-CSF at lo3 and 104 pg/mL were significantly lower than those in the absence of CSFs (P < .05 and P < .01, respectively; n = 5). Both the CD56+ cell count and the NK activity in the presence of rhGM-CSF (at lo2, lo3, and 104 pg/mL) were also significantly lower than those in the absence of CSFs (P < .05, P < .01, and P < .01, respectively; n = 5). In contrast, cultures performed in the presence of rhG-CSF at any dose showed no differences from those performed in the absence of CSFs (n = 5). from selected BM cells obtained from three healthy volunteers over time during culture. Figure 3 shows that the total cell count gradually increased during 21 days of culture in the absence of CSFs. In contrast, the total cell count increased rapidly in the first 7 days of culture in the presence of rhGM-CSF and rhG-CSF (each at 104 pg/mL). However, after 7 days, it began to decrease and finally returned to almost the initial value in the presence of rhGM-CSF. The value on day 7 in the absence of CSFs was significantly lower than that in the presence of both rhGM-CSF and rhG-CSF (P < .OS and P < .01, respectively; n = 3), but there was no significant difference between cultures performed with rhGM-CSF and rhG-CSF (n = 3). The values on day 14 also showed no significant differences (P > .05; n = 3). However, cultures performed in the presence of rhGM-CSF had a significantly lower cell count on day 21 than those undertaken in the absence of CSFs or in the presence of rhG-CSF (P < .01; n = 3).
Effects
There was no significant difference between those in the absence of CSFs and in the presence of rhG-CSF (n = 3).
Figures 4 and 5 show that the CD56+ cell count and NK activity increased rapidly from days 7 to 21 of culture both in the absence of CSFs and in the presence of rhG-CSF (104 pg/mL). In contrast, there was little increase in the presence of rhGM-CSF at lo4 pg/mL. The CD56+ cell count and NK activity in each culture did not differ significantly on day 7 (n = 3). However, the values on days 14 and 21 were significantly lower in the presence of rhGM-CSF than in the absence of CSFs and in the presence of rhG-CSF (P < .05 and P < .01, respectively; n = 3). However, there was no significant difference between cultures performed in the absence of CSFs and in the presence of rhG-CSF (P > .05; n = 3). Morphologic observation. Selected BM cells obtained from three healthy volunteers before culture consisted of granulocytes (90.3% 2 3.2%; mean f SD) and erythroid cells (4.2% f 3.9%), as well as a few lymphoid cells (3.3% f 3.1%), which did not include any LGL. As shown in Fig 6, LGL were generated after 7 days of culture, although they still formed only a small percentage of the total cells under each set of culture conditions. Granulocytes showed maximal proliferation after 7 days of culture, especially in the presence of rhGM-CSF and rhG-CSF at lo4 pg/mL. LGL rapidly increased in number from days 7 to LGL counts in the absence of CSFs and in the presence of rhGM-CSF or rhG-CSF were 1.22 f 0.23 x lo5, 2.02 f 0.45 x lo4, and 1.19 f 0.29 x lo5 after 14 days of culture, respectively, and 1.98 f 0.24 x lo5, 1.23 f 0.84 x lo4, and 1.90 ? 0.32 x 105 after 21 days of culture, respectively. The mean LGL counts after 14 and 21 days of culture in the presence of rhGM-CSF were significantly lower than in the absence of CSFs or in the presence of rhG-CSF (P < .05 and P < .01, respectively; n = 3), but there was no significant difference between cultures in the absence of CSFs and in the presence of rhG-CSF (n = 3).
Effects of rhGM-CSF and-rhG-CSF on PB NK cells. Figure 7 shows that CD56+ cells proliferated after 5 days of culture of PB MNC in a similar manner under any culture conditions. The CD56+ cell count was not significantly different at any period of culture under any set of conditions (n = 3).
DISCUSSION
Although the generation of NK activity from human BM cells has been described for some culture systems in IL-2-containing medium,*J0J2J4 the nature of the cells from which they are derived is still controversial. Because IL-2 can activate and expand mature T and NK cells,17 it is essential to eliminate all these cells from BM cells before culture. Therefore, selected BM cells obtained after the Using this culture system, we investigated the effects of rhGM-CSF and rhG-CSF on the generation of NK cells from selected BM cells. It was found that rhGM-CSF significantly suppressed the generation of CD56+ cells and NK activity in a dose-dependent manner, whereas rhG-CSF did not (Fig 2) . Suppression of the generation of CD56+ cells and NK activity was noted after 14 days of culture (Figs 4 and 5) . Morphologic observation showed that the generation of LGL was also suppressed in the presence of rhGM-CSF (Fig 6) . The CD56+ cell count, NK activity, and LGL count changed in parallel with one another under each set of culture conditions. Furthermore, the CD56+ cell count when PB MNC were cultured did not show any differences under all culture conditions up to 14 days of culture (Fig 7) , indicating that neither rhGM-CSF nor rhG-CSF affected the mature NK cells found in PB. These results suggest that rhGM-CSF suppresses the generation of NK cells, resulting in the in vitro suppression of NK activity.
The mechanism of the suppressive effect of rhGM-CSF on the generation of NK cells has not been determined, but two possibilities can be considered. One possibility is a direct effect of rhGM-CSF on NK progenitors, in which case the progenitors may have membrane rhGM-CSF receptors. The signal from such receptors might inhibit the differentiation and/or proliferation of NK progenitors directly or indirectly (eg, via the suppression of IL-2 receptor expression). The other possibility is an indirect effect mediated through other cells, such as macrophages. Actually, macrophages clearly showed an increase in their percentage after 14 days of culture in the presence of rhGM-CSF, the time when the generation of LGL was significantly suppressed compared with cultures in the absence of CSFs or in the presence of rhG-CSF (Fig 5) . Macrophages can produce cytokines that inhibit the differentiation and/or proliferation of NK progenitors. Therefore, we investigated the concentrations of some cytokines (prostaglandin Ez, interferon-a, and tumor necrosis factor-a) in the supernatant of each type of culture before and after 7, 14, and 21 days of culture. The preliminary results showed that these cytokines did not differ significantly between the different culture conditions at any time of culture (P > .05; n = 5) (data not shown). To clarify the mechanism of the inhibitory effect of rhGM-CSF on the generation of NK cells, BM NK progenitors are required for detailed characterization.
We have recently reported that the NK cell count and NK activity in PB and the frequency of BM NK progenitors were decreased after rhGM-CSF therapy in patients with AA and MDS.15 When rhGM-CSF is administered at 3 p,g/kg, its serum concentration reaches a level of lo3 pg/mL that is maintained for 9 hours.18 The present study showed that the inhibitory effect of rhGM-CSF on the generation of NK cells occurred at a concentration greater than lo2 pg/mL, indicating that rhGM-CSF therapy could suppress the generation of NK cells in patients with granulocytopenia, as we have already r e~0 r t e d . l~
